524506 — Coral Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual income statement for Coral Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	706	966	756	781	837
Cost of Revenue
Gross Profit	258	408	305	259	464
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	669	823	681	760	696
Operating Profit	37.1	143	75.6	21.1	141
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	91.2	176	119	82.3	207
Provision for Income Taxes
Net Income After Taxes	71.3	136	90.5	64.5	158
Net Income Before Extraordinary Items
Net Income	71.3	136	90.5	64.5	158
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	71.3	136	90.5	64.5	158
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	20	37.9	23.3	18	44.5
Dividends per Share